Syapse Receives $25,000,000 Series C Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    101 University Ave. Palo Alto, CA 94301 USA
  • Company Description
    Built on a powerful cloud-based semantic data platform, Syapse applications enable the generation and use of omics profiles in diagnosing and treating patients at diagnostic companies, research institutions, medical centers, and payers.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    Syapse has built a market-leading position in the clinical implementation of precision medicine for oncology and will use this funding round to drive the rapid expansion of its category-defining software, Syapse Precision Medicine Platform, in community health systems.
  • M&A Terms
  • Venture Investor
    Ascension Ventures
  • Venture Investor
    The Social+Capital Partnership
  • Venture Investor
    Safeguard Scientifics

Trending on Xconomy